Market Report

Sufentanil , also known as R30730 or brand name Sufenta, is a synthetic opioid analgesic drug which is considerably more potent than its parent drug, fentanyl, morphine. It is used for producing anesthesia for surgery. It may also be used with other medicines as part of epidural anesthesia during labor and delivery to decrease pain. Globally, development of efficient and advanced technology and increase in number of medical surgeries and gynaecological surgeries are the prime growth drivers of Sufentanil Citrate market. Apart from this, augmentation in cardiovascular diseases and associated surgeries, and emerging economies are expected to be the key growth drivers during the period of study. Request Sample   Geographically North America dominates the  sufentanil citrate market  driven by best in class infrastructure, easy access to healthcare, higher awareness amongst physicians about the advanced technological treatment, higher spending on R&D by large pharmaceutic...